Related Experiment Video
Updated: Jul 2, 2026
05:19
Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
Published on: July 7, 2023
Bipolar depression: trial-based insights to guide patient care
David E Kemp1, David J Muzina, Roger S McIntyre
1Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, Ohio, USA. kemp.david@gmail.com
Dialogues in Clinical Neuroscience
|August 12, 2008
Summary
Treating bipolar depression is challenging, with limited options available. This review summarizes evidence-based pharmacological treatments for managing bipolar depression, offering a clinical approach for patients.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Medicine
Background:
- Bipolar depression is the most debilitating aspect of bipolar disorder.
- Limited effective treatments exist for bipolar depression, representing a significant unmet need.
- Patients experience more depressive than manic episodes and have higher suicide attempt rates during depression.
Purpose of the Study:
- To provide an evidence-based summary of pharmacological treatments for acute and long-term management of bipolar depression.
- To review clinical trial data for various compounds used in treating bipolar depression.
- To present a pragmatic clinical approach for managing the depressed phase of bipolar disorder.
Main Methods:
- Review of clinical trial results for pharmacological treatments.
- Examination of traditional mood stabilizers (lithium, divalproex), atypical antipsychotics, unimodal antidepressants, and modafinil.
- Analysis of treatment efficacy using number needed to treat and effect size.
Main Results:
- Efficacy data for various pharmacological agents were reviewed.
- Differences in effectiveness among treatments were discussed.
- A clinical approach for managing bipolar depression was outlined.
Conclusions:
- Effective pharmacological management of bipolar depression remains a critical challenge.
- A comprehensive review of current treatments and a pragmatic approach are essential for clinical practice.
- Further research into novel therapeutics for bipolar depression is warranted.
Related Concept Videos
01:30Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...